EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C43H58N4O12 |
| Net Charge | 0 |
| Average Mass | 822.953 |
| Monoisotopic Mass | 822.40512 |
| SMILES | CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C |
| InChI | InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1 |
| InChIKey | JQXXHWHPUNPDRT-WLSIYKJHSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Escherichia coli (ncbitaxon:562) | - | PubMed (21988831) |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | DNA synthesis inhibitor Any substance that inhibits the synthesis of DNA. leprostatic drug A substance that suppresses Mycobacterium leprae, ameliorates the clinical manifestations of leprosy, and/or reduces the incidence and severity of leprous reactions. Escherichia coli metabolite Any bacterial metabolite produced during a metabolic reaction in Escherichia coli. pregnane X receptor agonist An agonist that selectively binds to and activates a pregnane X receptor. EC 2.7.7.6 (RNA polymerase) inhibitor An EC 2.7.7.* (nucleotidyltransferase) inhibitor that interferes with the action of RNA polymerase (EC 2.7.7.6). antitubercular agent A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis. protein synthesis inhibitor A compound, usually an anti-bacterial agent or a toxin, which inhibits the synthesis of a protein. |
| Applications: | leprostatic drug A substance that suppresses Mycobacterium leprae, ameliorates the clinical manifestations of leprosy, and/or reduces the incidence and severity of leprous reactions. antiamoebic agent An antiparasitic agent which is effective against amoeba, a genus of single-celled amoeboids in the family Amoebidae. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. antitubercular agent A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis. geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| rifampicin (CHEBI:28077) has role Escherichia coli metabolite (CHEBI:76971) |
| rifampicin (CHEBI:28077) has role angiogenesis inhibitor (CHEBI:48422) |
| rifampicin (CHEBI:28077) has role antiamoebic agent (CHEBI:171664) |
| rifampicin (CHEBI:28077) has role antineoplastic agent (CHEBI:35610) |
| rifampicin (CHEBI:28077) has role antitubercular agent (CHEBI:33231) |
| rifampicin (CHEBI:28077) has role DNA synthesis inhibitor (CHEBI:59517) |
| rifampicin (CHEBI:28077) has role EC 2.7.7.6 (RNA polymerase) inhibitor (CHEBI:37416) |
| rifampicin (CHEBI:28077) has role geroprotector (CHEBI:176497) |
| rifampicin (CHEBI:28077) has role leprostatic drug (CHEBI:35816) |
| rifampicin (CHEBI:28077) has role neuroprotective agent (CHEBI:63726) |
| rifampicin (CHEBI:28077) has role pregnane X receptor agonist (CHEBI:77318) |
| rifampicin (CHEBI:28077) has role protein synthesis inhibitor (CHEBI:48001) |
| rifampicin (CHEBI:28077) is a N-iminopiperazine (CHEBI:46847) |
| rifampicin (CHEBI:28077) is a N-methylpiperazine (CHEBI:46920) |
| rifampicin (CHEBI:28077) is a cyclic ketal (CHEBI:59779) |
| rifampicin (CHEBI:28077) is a hydrazone (CHEBI:38532) |
| rifampicin (CHEBI:28077) is a rifamycins (CHEBI:26580) |
| rifampicin (CHEBI:28077) is a semisynthetic derivative (CHEBI:72588) |
| rifampicin (CHEBI:28077) is tautomer of rifampicin zwitterion (CHEBI:71365) |
| Incoming Relation(s) |
| 2'-hydroxyrifampicin (CHEBI:111544) has functional parent rifampicin (CHEBI:28077) |
| 21-phosphorifampicin (CHEBI:140276) has functional parent rifampicin (CHEBI:28077) |
| rifampicin zwitterion (CHEBI:71365) is tautomer of rifampicin (CHEBI:28077) |
| IUPAC Name |
|---|
| (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate |
| INNs | Source |
|---|---|
| rifampicin | KEGG DRUG |
| rifampicina | DrugBank |
| rifampicinum | DrugBank |
| Synonyms | Source |
|---|---|
| 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV | ChemIDplus |
| RFP | DrugBank |
| rifamcin | ChEBI |
| Rifampicin | KEGG COMPOUND |
| Rifampin | KEGG COMPOUND |
| Manual Xrefs | Databases |
|---|---|
| C06688 | KEGG COMPOUND |
| D00211 | KEGG DRUG |
| DB01045 | DrugBank |
| HMDB0015179 | HMDB |
| NL6509961 | Patent |
| RFP | PDBeChem |
| Rifampicin | Wikipedia |
| US3342810 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:5723476 | Reaxys |
| CAS:13292-46-1 | KEGG COMPOUND |
| CAS:13292-46-1 | ChemIDplus |
| Citations |
|---|